Pharma & Biotech

The biotech sector often presents a fascinating dichotomy, and Axsome Therapeutics currently embodies it perfectly. The company is experiencing a...

As Johnson & Johnson shares trade near their annual peak, a compelling dynamic is unfolding behind the scenes. The contrasting...

A significant strategic move by Canadian biotechnology firm Bionxt Solutions could mark a pivotal moment for the company. On December...

Time is running out for investors in CureVac, the former mRNA pioneer, as a critical deadline approaches. The company's acquisition...

Having recently surpassed the historic $1 trillion market capitalization milestone, pharmaceutical titan Eli Lilly now faces pressure on its share...

The shares of Redcare Pharmacy have endured a punishing year for investors, with more than half of the company's market...

Shares of Solid Biosciences traded lower on Monday, shedding as much as 3.6% in value even as the biotechnology firm...

The year 2025 has been a period of intense transformation for Recursion Pharmaceuticals, a biotechnology firm whose shareholder base expanded...

Eli Lilly & Co. made corporate history by becoming the first pharmaceutical firm to surpass a $1 trillion market valuation....

A leading financial institution has issued a stark warning for investors in Novo Nordisk, suggesting the Danish pharmaceutical giant's stock...